Date Title PDF Version
09/20/23 Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
09/05/23 Aadi Bioscience to Participate at Upcoming Investor Conferences
08/09/23 Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update
08/02/23 Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update
05/25/23 Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
05/23/23 Aadi Bioscience to Participate in Upcoming Investor Events
05/10/23 Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial
05/03/23 Aadi Bioscience to Report First Quarter 2023 Results and Operational Update
04/26/23 Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
04/14/23 Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
04/06/23 Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023
03/28/23 Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update
03/27/23 Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
03/26/23 Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer
03/15/23 Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update
03/03/23 Aadi Bioscience Announces Leadership Transition
02/22/23 Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference